Protein kinases in vascular smooth muscle tone--role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction.
about
Prostaglandin E2 induces contraction of liver myofibroblasts by activating EP3 and FP prostanoid receptorsAcute oxygen-sensing mechanisms.Induction of ANGPTL4 expression in human airway smooth muscle cells by PMA through activation of PKC and MAPK pathways.Interaction between src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery.ROS-dependent signaling mechanisms for hypoxic Ca(2+) responses in pulmonary artery myocytes.Activation of the EGFR/p38/JNK pathway by mitochondrial-derived hydrogen peroxide contributes to oxygen-induced contraction of ductus arteriosusThe effects of endogenous sex hormones and acute hypoxia on vasoconstriction in isolated rat pulmonary artery rings.Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes.Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-δ-mediated JNK Phosphorylation.Pathogenic role of store-operated and receptor-operated ca(2+) channels in pulmonary arterial hypertension.Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2+ entry.Mechanisms controlling vascular tone in pulmonary arterial hypertension: implications for vasodilator therapy.Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitroRegulation of heterotrimeric G protein signaling in airway smooth muscle.Mechanisms of oxygen sensing: a key to therapy of pulmonary hypertension and patent ductus arteriosus.Lipid emulsion inhibits vasodilation induced by a toxic dose of bupivacaine by suppressing bupivacaine-induced PKC and CPI-17 dephosphorylation but has no effect on vasodilation induced by a toxic dose of mepivacaineTherapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine.Mitochondrial ROS-PKCepsilon signaling axis is uniquely involved in hypoxic increase in [Ca2+]i in pulmonary artery smooth muscle cells.Rho kinase and protein kinase C involvement in vascular smooth muscle myofilament calcium sensitization in arteries from diabetic rats.Notoginsenoside R1 attenuates hypoxia and hypercapnia-induced vasoconstriction in isolated rat pulmonary arterial rings by reducing the expression of ERK.Superoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca(2+) sensitization.Modulation of PGF2alpha- and hypoxia-induced contraction of rat intrapulmonary artery by p38 MAPK inhibition: a nitric oxide-dependent mechanism.Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia.Role of reactive oxygen species and sulfide-quinone oxoreductase in hydrogen sulfide induced contraction of rat pulmonary arteries.Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation.Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and Rho kinase antagonists.ROK controls urethral tone, but by what mechanism?Hypoxic pulmonary vasoconstriction
P2860
Q28569384-ED1CA26A-F260-4CC0-9325-E9B9F46C789AQ33577287-B5ABF6F0-EF76-475E-AF62-F1EA48405A83Q33625241-262CC3EB-F94F-4B7C-ACC3-CA8071D4730CQ33703906-8B06F891-78E2-4ECD-97CC-C05FA7EAA4CFQ33818152-9627B9C1-D897-4ABE-8D11-EB6096E265B9Q34051516-59237993-5399-4CBC-98B2-648127747855Q34089619-A34FCECD-484F-4FA1-B3BE-87230117F22CQ35751857-161426C4-DFE5-4D28-A245-238DD79395BEQ36064282-F4873E87-5FA9-4A68-A63A-88BBCDB710CEQ36302411-8083B090-EE90-4752-8703-00C96A5CEC0FQ36440965-A7A6BD55-33BF-46FE-AC99-9951D043A208Q36674960-46E28294-AD88-4D11-A19D-30F6C764208AQ36956200-BA547D59-5000-4929-A3B8-2E12463C61F2Q37038052-8CA3E767-F7AD-48CD-90A3-345B0C853D7FQ37222238-2BF0AA6A-B6B3-4A99-8FF5-64DE26AE75D4Q37334705-B92597E8-250B-44A4-AC3D-A0F9FD4301F2Q37754900-D37D5F98-1B02-4861-A5C8-CAE96C0DF65FQ42007657-EC89467D-8C9C-46C0-8A4C-9F86BA6E2245Q42251635-B807F455-A584-4386-891E-F1B4F3D8A938Q42704895-2D5EB584-2EE4-4900-84D3-40A99F4F779BQ46186037-176F2CF8-DF64-454A-A35F-51185FADF163Q46627972-4E15B50C-9ECF-498E-97D6-7650ABDB5C9DQ46628245-A4127414-6696-4EE6-9F46-2AF0E8CCAEB3Q49918009-65E0F6F9-B860-4511-AE97-71AFEBEFF13CQ50711800-BCBA5586-F47A-4C65-9FA0-A8A3573A9FFAQ53545947-5B644CEC-044B-4070-84CB-40D7751BC33EQ54640590-D3B53CCD-7CD1-4745-B4E9-0F5E5D9DBA06Q57099542-6AAC2060-18FB-43E1-A94B-DC0443ABBBA4
P2860
Protein kinases in vascular smooth muscle tone--role in the pulmonary vasculature and hypoxic pulmonary vasoconstriction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Protein kinases in vascular sm ...... ic pulmonary vasoconstriction.
@ast
Protein kinases in vascular sm ...... ic pulmonary vasoconstriction.
@en
type
label
Protein kinases in vascular sm ...... ic pulmonary vasoconstriction.
@ast
Protein kinases in vascular sm ...... ic pulmonary vasoconstriction.
@en
prefLabel
Protein kinases in vascular sm ...... ic pulmonary vasoconstriction.
@ast
Protein kinases in vascular sm ...... ic pulmonary vasoconstriction.
@en
P2093
P1476
Protein kinases in vascular sm ...... ic pulmonary vasoconstriction.
@en
P2093
Greg A Knock
Jeremy P T Ward
Philip I Aaronson
Vladimir A Snetkov
P304
P356
10.1016/J.PHARMTHERA.2004.08.009
P577
2004-12-01T00:00:00Z